chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 10 minutes after vaccines administered, patient became flushed in face with some rash, drooling, runny nose, gagging, and coughing. Sent to ER.
Coworker and I were administered flu shot on 10/22/08.  From what I read, symptoms should not be occuring, but both of us are experiencing the same symptoms:  flu like symptoms, fatigue, sore throat, dry cough, slight fever.  Both of us just do not feel well and normally do not fall ill.  No one else in the office has received the shot or nasal spray, has fallen ill, or become infected by either of us.  Also, site of injection was usually sore compared to the previous 5 years I have received the flu shot.
Patient had a positive COVID test on 1/6/2022 and expired on 2/24/2022.
Have lost 14 pounds because I am nauseous all the time; I continue to have nausea; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of WEIGHT DECREASED (Have lost 14 pounds because I am nauseous all the time) and NAUSEA (I continue to have nausea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced WEIGHT DECREASED (Have lost 14 pounds because I am nauseous all the time) and NAUSEA (I continue to have nausea). At the time of the report, WEIGHT DECREASED (Have lost 14 pounds because I am nauseous all the time) and NAUSEA (I continue to have nausea) outcome was unknown.            No concomitant medication included. No treatment medication included. Action taken with mRNA-1273 in response to the event was not applicable.
got the strain of flu it didn't cover. Got Hospitalized; Initial information received on 28-Dec-2022 regarding an unsolicited valid Social Media serious case received from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who got the strain of flu it (vaccine) didn't cover and got hospitalized after receiving Influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect Influenza vaccine produced by unknown manufacturer (administration site, form, strength, frequency, route, expiry date, lot number not reported) for prophylactic vaccination.  On an unknown date the patient got the strain of flu it didn't cover. got hospitalized (influenza) (latency: unknown) after the administration of Influenza vaccine.   Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event.  Outcome: Unknown.  Seriousness criteria: event caused hospitalization for the Influenza; Sender's Comments: Sanofi Company Comment dated 30-Dec-2022: This case involves an unknown age and unknown gender patient who got the strain of flu it (vaccine) didn't cover and got hospitalized after receiving Influenza vaccine. The time to onset is not reported with the role of the vaccine. The clinical course of the event was not provided. Furthermore, information regarding condition at the time of vaccination, previous vaccination history, role of medical history, concomitants,  hospitalization details, lab data excluding other predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of an individual vaccine cannot be assessed.
Was notified by Hospital Epidemiologist that patient was admitted on November 3, 2007 with progressive weakness progressing to respiratory failure.  Presumptive diagnosis of Guillain-Barré Syndrome(GBS). At present under medical treatment on mechanical ventilation in  ICU. Follow-up: On 11/14/2007 patient was diagnosed with GUILLAIN-BARRE Syndrome by the neurologist.  01/17/2008 MR received for DOS 11/03/2007-1/13/2008 with DX:  Guillain-Barre Syndrome, Respiratory Failure, Diabetes Mellitus Type 2, UTI, Bedridden.  Pt initially presented with c/o intractable abdominal pain with gastritis confirmed per endoscopy (also GERD and esophagitis). Pt developed lower extremity weakness and decreased sensation noted 11/6/07.  Neuro consult with differential dx of atypical early Guillain-Barre. (+) neuropathic pain. Ataxia noted 11/6/07. DTR loss noted 11/12/07 as well as respiratory failure. Pt intubated, placed on mechanical ventilation and transfered to ICU. By 12/7/07 Neurophysiology consult reports Axonal Acute Inflammatory Polyneuropathy with evidence of a loss of axons of approx 80%. Evidence of demyelination in all 4 extremities. Prognosis poor. 1/15/2010 Patient was discharged home January 13, 2008 on mecbonic ventitlator, bedridden.
4 hrs p/vax pt woke from a nap crying unconsolably; not even a pacifier would help; then got very pale, lips turned white-looked like a dead baby; very limp; approx 20 minutes;
called in sick 12/30/20, having fever, chills, body aches, cough, sore throat, and headache, tested for COVID 1/4/2021 it was Negative
Patient passed out after receiving COVID-19 vaccine while waiting in the waiting area. His BP was taken and read at 127/80 and 124/92. He fell from his chair and then as he laid on the floor for a while he felt better. He got a ride home.
suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
she had her lower right lobe of her lung removed; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received pf-06928316 (ABRYSVO), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LUNG LOBECTOMY (medically significant) with onset 2022, outcome "unknown", described as "she had her lower right lobe of her lung removed". Last year the patient had her lower right lobe of her lung removed and this year she's got to have, within the next 2 or 3 weeks, her upper left lobe of her lung removed, and her insurance denied her the RSV vaccination. Which her doctor's wanted her to have.  The information on the batch/lot number for pf-06928316, pf-06928316  has been requested and will be submitted if and when received.
I can say that my symptoms actually started on my first dose 12-17-2020, experienced chills, muscle soreness, had fever of 99.4F and thought it was menopausal symptoms.  After my second dose vaccine, my lymph nodes were visibly enlarged. I experienced muscle soreness, lymph nodes were enlarged, left side, had chills, sore throat, ear ache radiated towards my neck and had a viral pink eye. I felt very tired and had muscle aches. I had a fever of 99.4F, mostly chills and joint pain to my left shoulder, left hip and left knee. I also had 3 Covid swab testes which were all negative.  I saw my doctor who performed a x-ray of the chest and has put off a mammogram test till April 2021. At this time I have not recovered there is something going on with my pelvis, form my iliac crest when bending down I feel a pinched lymph node on that area of iliac crest. I get a pinch on my pelvis that is painful.
Pt. c/o feeling flush in the face and slight chest congestion.  Pt. voice that he had a history of bypass and ablation.  Pt. seen and assessed by EMT and vitals are:  Bp 140/90, HR 74, O2 97%.  After 20 min. of observation pt. voiced that he felt ell enough to go home and was cleared to do so by EMT.
has covid; has covid; booster; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 64 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 2), for COVID-19 Immunization; Bnt162b2 (Dose: 1), for Covid-19 immunization. The following information was reported: IMMUNISATION (prolonged hospitalization, medically significant), outcome "unknown", described as "booster"; DRUG INEFFECTIVE (hospitalization, medically significant), COVID-19 (hospitalization, medically significant), outcome "unknown" and all described as "has covid". The patient was hospitalized for drug ineffective, covid-19 (start date: 30Dec2021). The event "has covid" and "has covid" was evaluated at the physician office visit.  Clinical course was reported as: Patient stated she was in quarantine. She was feeling lousy, fever, vomit and achy after receiving a booster. She went to the clinic on 28Dec and found out she has an infection. Patient was getting worst 30Dec patient went to hospital and doctor told patient has covid.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Lethargy, Hypotension, Bradycardia , diaphoresis following vaccination. Symptoms resolved within ten minutes Initial VS 80/46 56 16 O2 sat 98%, VS 10 mins later 110/76 62 12 99%
Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Headache-Mild, Additional Details: Patient was given an epi-pen and the ambulance was called.  She was checked out by the paramedics and went home.
Jerking of head and right arm for 5-10 seconds at 3 separate time.
devel 1 blister on rt arm 12hr p/vax;had 2nd blister 24hr later;4-5 days later child told mom to look @ arm-had blisters w/scabbing approx size of dime;area had pus drainage;area cont to enlarge  size of a lemon;saw MD;impetigo type rash
starting March14 patient experienced occasional headaches eventually experienced loss of balance by week of Apr 12 Apr 16 admitted to ER with subdural hematoma
5 inch rash on right forearm (injection site was left arm) at 12:30AM on 5/8/21 persisting for 30 mins. Headache, fatigue, full body ache and left arm ache persisting entirety of 5/8/21. Lips swollen (NO stinging, numbness, etc., just appeared swollen) from 10:25am-11AM on 5/8/21. Cluster of 3 small, itchy bug-bite type blemishes on chin- itchiness from 10:30am-3:00pm on 5/8/21, cluster remains now but went down in size. Nausea 4:30pm-7:30pm 5/8/21. Diarrhea once at 5:45pm on 5/8/21. Heartburn (which I do not usually experience) in the evening hours of 5/8/21. Increase in appetite first half of 5/8/21, loss of appetite second half of 5/8/21. Fever of 100.1 at 6:30pm on 5/8/21, increasing to 101.3 by 7pm which went down after taking a fever reducer (Extra strength acetominaphin). Woke on 5/9/21 with pink circular patch (2?X2?) that was swollen and warm to touch at injection site. Went down slightly with cold compress.
Patient was complaining of left ear pain, nausea, vomiting and dizziness.  Since admission to Hospital, patient has had a lumbar drain placed and she has experienced now right Cranial Nerve VII and left Cranial Nerve VI palsy.  She has been hospitalized for 22 days so far.   Recently on 5/13 Patient had a right frontal craniotomy for open bx and clx.  Now recommending IVIG.
This spontaneous report as received from a healthcare worker refers to a 24 years old female patient with no pertinent medical history and no drug reactions or allergies who on 14-JUL-2012, was vaccinated intramuscularly with 0.5 ml dose of GARDASIL (lot number not reported). No other co-suspects were reported. No concomitant medications were reported. The healthcare worker reported that on 15-JUN-2012, the patient developed tingling, bruising and redness at the injection site after GARDASIL was administered. No lab diagnostics studies were performed. No treatment was given for the experience. It was stated that the tingling and bruising were improving, however, the redness had not improved. The patient sought medical attention by contacting the physician. The relatedness for patient developed tingling, redness and bruising at the injection site was unknown for GARDASIL. Additional information has been requested.
Narrative: Patient received a covid EUA (J&J) vaccine on 6/25/2021. Pt presented to ER at hospital outside facility on 11/12/22. Pt's admitting Diagnosis: Congestive heart failure. Pt died at this facility on 11/27/2022. This death is not related to the covid vaccine. Reporting this death since vaccine was EUA status.
Information has been received from a Medical assistant concerning an approximately 65 year old patient who on 16-DEC-2010 was vaccinated with a dose of ZOSTAVAX (lot number not provided). On 18-JAN-2011 the patient reported to the practice with shingles (onset day not specified). It was reported a treatment with LIDODERM, famciclovir and MEDROL dose pack. At the time of the report the patient had not recovered. Follow up information was received from a nurse practitioner concerning the 65 year old male patient with hypertension, hyperlipidaemia, benign prostatic hyperplasia, chronic kidney disease, hypothyroidism, psoriasis, diverticulitis, kidney stone, rhinitis allergic and no acute illness at time of vaccination who on 16-DEC-2010 was vaccinated at 12:15p.m, IM, at the right upper arm, with the first dose of ZOSTAVAX. The nurse stated that on 19-JAN-2011 the patient reported 3 day rash at the left upper chest axilla, complained of pruritis and 2 papular vesicular lesions consisted with herpes zoster identified. It was given LIDODERM and famciclovir 500mg for 7 days as a treatment for the adverse events. On 23-JAN-2011 the patient recovered. Additional information is not expected.
The night of the vaccine I had extreme restlessness and malaise and couldn't sleep whole night. The next day I had extreme chills, so bad I could barely stop shaking to use my computer for work. Also had a high fever of 103.5° and other symptoms similar to the worse case of the flu I used to get before I started getting annual flu shots years ago. Stiff neck, leg pains, sore skin, very tired, hard to think. Very debilitating and the worse reaction I've ever had to a vaccine. Also, the sorest my arm has ever been after a shot. On 3rd day I luckily feel  a little better. I do wonder this. I'm sure there was no one like me included in the clinical trials. About 1 1/2 months ago after being bitten by a bat, I had to undergo a three week series of rabies shots. With having such a severe reaction to the Shingles shot I wonder if that could have anything to do with it?
PCP note reads myalgias, pruritus, general achiness and possibly a fever. Also a headache, resolved within 6 hours of injection.
Raised size of quarter to half dollar circumference,  red and surrounding area 1/2 inch red like cellulitis.
This spontaneous report was received from a pharmacist refers to a female patient of unknown age. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not provided. On an unknown date, the patient was vaccinated with ZOSTAVAX for prophylaxis (dose, strength, vaccination site, route unspecified). On an unknown date, the patient experienced injection site rash, injection site warmth and injection site swelling following the administration of ZOSTAVAX. The patient sought medical attention and contacted pharmacist. The outcome of the events was reported as not recovered. Product quality complaint (PQC) was not involved. No further information was provided. Varicella Zoster Virus Identification Program (VZVIP) packet was offered and declined.     Additional information has been requested.
Patient had shortness of breath and felt scratchy behind her throat. 1 pen of Epinephrine  IM 0.3 mg was given to patient on her left thigh as soon as patient felt uneasiness on her throat. 911 was called while epipen shot was given.  EMT came and checked her stability and vitals. Patient signed the waiver of not going to hospital to EMT. Patient stayed in the pharmacy for 1 hour.
low grade fever; This case was reported by a consumer via call center representative and described the occurrence of low grade fever in a 57-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, 1 day after receiving Shingrix, the patient experienced low grade fever. On an unknown date, the outcome of the low grade fever was unknown.   It was unknown if the reporter considered the low grade fever to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient experienced low grade fever after vaccination. The patient asked can develop a fever the day after the shingrix shot if did not have it the first night.
Acute numbness and thinking in pinky and ring finger is left hand. Ongoing since onset 24-7. No diagnosis yet, awaiting appointments and further tests. Not sure if it is related or coincidental but wanted to report in case it is.
Lethargic; Pain at the injection site; Tired for a day; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 07-Sep-2021 and was forwarded to Moderna on 07-Sep-2021.    This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargic), VACCINATION SITE PAIN (Pain at the injection site) and FATIGUE (Tired for a day) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concurrent medical conditions included COPD.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LETHARGY (Lethargic), VACCINATION SITE PAIN (Pain at the injection site) and FATIGUE (Tired for a day). At the time of the report, LETHARGY (Lethargic), VACCINATION SITE PAIN (Pain at the injection site) and FATIGUE (Tired for a day) outcome was unknown.            Patient reported that the Patient took inhalers for COPD. Concomitant medications were not provided.    This case was linked to MOD-2021-311057, MOD-2021-311064 (Patient Link).
Had negative covid test 1/6/21.  Recieced vaccine,  in 24 hours had body aches, low grade temp lasting 24 hours.  1/6/21 had headache at lunchtime, by evening no taste.  1/7/21 head congestion, headache, loss of taste and smell had covid test which came out positive.
Start 12/31/2020 tired, muscle tightness in upper back between shoulder blades, more energy, feeling more focused, tiredness
Case number PHEH2016US030408, is an initial spontaneous report received from a pharmacist on 17 Nov 2016. This report refers to a patient of an unknown age and gender. Medical history and concomitant medication were not reported. The patient was vaccinated with FLUAD (lot number: 166103, expiration date: Apr 2017) from an unknown start date at a dose of 0.5 ml (frequency: one single dose), intramuscularly. On an unknown date, the plunger did not move when vaccine was tried to be administered. He (the reporter) then put the needle in the patient's arm and started to push and nothing happened and again trued with another prefilled syringe and the same thing happened. It was further reported that a product complaint was also filed. The outcome of the events was reported as unknown. The seriousness and causality for the events were not reported.
Case PHEH2016US023446 is an initial spontaneous report received from nurse on 13 Sep 2016. This case refers to 35 year old patient of unknown gender. Past medical history and concomitant medications were not reported. The patient was vaccinated with single dose of FLUVIRIN, batch number 1515701, expiry date: not reported) at a dose of 0.5 ml intramuscular into left arm on 01 Dec 2015. It was reported that, the patient received FLUVIRIN MDV that had been exposed to 8 to 10 temperature excursion and it was administered to unknown number of patients. No adverse event was reported following this medication error.
adverse effect; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (adverse effect) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (adverse effect). At the time of the report, VACCINATION COMPLICATION (adverse effect) outcome was unknown.            No relevant concomitant medications were reported. Treatment information was unknown.
So I ended up having Shingles in the back of my head four months (Feb. 24, 2022) after being vaccinated. It was on my left side of my face and shoulder.
Per pt's mother, pt received FLUMIST on Friday 11/06/09 and recurrent epistaxis since then.  Labs pending:  CBC with Diff, PT, PTT, INR.
24 - 48 hours post vax the pt experienced nausea, headaches and body and joint aches; especially knees, elbows and hips. Left arm was red and swollen from elbow to shoulder with warmth in general area. Pt also felt general malaise. Attending physician felt pt may have sterile abscess. Pt treated with Tylenol and applied cold compress to left arm. Pt did not have a fever at the time of examination. Follow up information received from a CNP stated that the pts symptoms had completely resolved within one week of onset. No prescription drugs were used.
Pain in shoulder joint of arm where injected.  Pain increased during the day to the point of incapacitation.  Pain developed in opposite shoulder, both hips, both knees -- but not nearly so severe.  I have experienced bone breaks such as trimalleolar fracture; this was worse.  Pain peaked at 12 hours post-injection, then decreased over next 48 hours.  72 hours after injection, pain is substantially subsided.
tested positive for COVID-19; This is a spontaneous report from a contactable consumer (Patient) via Pfizer-sponsored program CEP/PSP ID: 159558.  A 73-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE. Formulation: Solution for injection, Lot# UNKNOWN), via unspecified route of administration on 04Feb2021 (at the age of 73 years-old) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On 13Feb2021, patient tested positive for COVID-19. The patient underwent lab test which included SARS-COV-2 Test: Positive on 13Feb2021. Patient was told by the health department that he needs to remain in isolation for 10 days. Patient was scheduled for his second dose of the Pfizer COVID-19 vaccine on 25Feb2021 and would like to know if he will be able to receive his second dose of the Pfizer COVID-19 vaccine on the scheduled appointment date.   Information of lot/batch number has been requested.
PATIENT WAS GIVEN AN UNDILUTED VERSION OF THE PEDIATRIC PFIZER VACCINE (5-11 YEARS)